Mirae Asset Global Etfs Holdings Ltd. Organogenesis Holdings Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 37,381 shares of ORGO stock, worth $169,335. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,381
Previous 42,290
11.61%
Holding current value
$169,335
Previous $182,000
25.27%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ORGO
# of Institutions
123Shares Held
69.9MCall Options Held
15.1KPut Options Held
25-
Soleus Capital Management, L.P. Greenwich, CT12.3MShares$55.9 Million3.5% of portfolio
-
Morgan Stanley New York, NY12.1MShares$54.6 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN6.78MShares$30.7 Million3.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.2MShares$23.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$23 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $593M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...